{
  "title": "4.1 Real World Studies",
  "hero": {
    "class": "flex",
    "title": "NINLARO<sup>&reg;</sup> (ixaomib) Real-World Studies",
    "subheading" :"<p>NINLARO has a wealth of real-world evidence (RWE) across a range of patient populations<sup>1-5</sup></p>",
    "cta": {
      "classes": ["color--secondary"],
      "url": "#test",
      "text": "Download RWE Brochure",
      "icon": "icon-chevron-right"
    }
  },
  "centeredCallout": {
    "heading": "<p>The NINLARO regimen provided long-term efficacy and manageable tolerability in the TOURMALINE-MM1 clinical trial<sup>1-5</sup></p>",
    "links": [
      {
        "url": "#test",
        "text": "Discover MM1 Efficacy",
        "icon": "icon-chevron-right"
      },
      {
        "url": "#test",
        "text": "Discover MM1 Safety",
        "icon": "icon-chevron-right"
      }
    ]
  },
  "dataViz1": {
    "bgColor": true,
    "heading": {
      "type": "div",
      "heading": "Data-viz with heading"
    },
    "image": {
      "src": "images/charts/4.1_trials.svg",
      "srcSmall": "images/charts/4.1_trials-mobile.svg",
      "alt": ""
    },
    "referenceList": {
      "type": "ul",
      "items": [
        {
          "item": "Unadjusted, indirect comparison for illustration only; clinical significance is not implied. Cross-trial comparisons are potentially confounded by differences in trial design and study population"
        },
        {
          "item": "There was potential overlap<sup>‡</sup> in study populations in Terpos et al, Hájek et al, and Minarik et al due to inclusion of patients from the same registry"
        }
      ]
    }
  }
}